Evaluation of Nasal Biomarkers for Objective Assessment of Disease Severity in Respiratory Disorders
This research study is an observational, single site study quantifying expression of biomarkers of respiratory disease in nasal fluid using the ABEL microsampler device. The primary objective of this study is to compare biomarker expression between healthy controls and participants with respiratory disorders such as chronic obstructive pulmonary disorder (COPD), hayfever, chronic sinusitis, asthma and rhinitis.
100 Clinical Results associated with Diag-Nose Medical Pty Ltd
0 Patents (Medical) associated with Diag-Nose Medical Pty Ltd
100 Deals associated with Diag-Nose Medical Pty Ltd
100 Translational Medicine associated with Diag-Nose Medical Pty Ltd